Associations between serological evidence of SARS-CoV-2 infection and longitudinal pulmonary outcomes among people with HIV: analysis of the MACS/WIHS combined cohort study (MWCCS)
Among individuals with serologic evidence of SARS-CoV-2 infection, HIV serostatus was not associated with greater declines in pulmonary function or worsening of respiratory symptoms. Our findings suggest that having HIV alone may not increase the risk for pulmonary impairments following a SARS-CoV-2 infection. Further research is needed to understand how uncontrolled HIV infection and severity of SARS-CoV-2 infection may increase risks of adverse pulmonary outcomes following a SARS-CoV-2 infection.
Authors
- Catie Wiener
- Valentina Stosor
- Jodie A. Dionne
- Stephen J Gange
- M. Bradley Drummond
- Catalina Ramirez
- Lakshmanane Premkumar
- Michelle A Floris-Moore
- Alicia E Diggs
- Meredith C McCormack
- Divya B Reddy
- Igor Z Barjaktarevic
- Ken M Kunisaki
- Beverly E Sha
- Stephen R Cole
- Robert F Foronjy
- Maria L Alcaide
- Andrew Edmonds
- Deepa G Lazarous
- Laurence Huang
- Alison Morris
- Sushma K Cribbs
Institutions
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- Rush University Medical Center (US)
- Albert Einstein College of Medicine (US)
- Johns Hopkins University (US)
- University of Miami (US)
- Emory University (US)
- University of California, Los Angeles (US)
- University of Pittsburgh (US)
- SUNY Downstate Health Sciences University (US)
- Georgetown University (US)
- University of Alabama at Birmingham (US)
- Boise VA Medical Center (US)
- University of St. Francis (US)
Publication Details
- Journal
- Respiratory Research
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1186/s12931-026-03542-4
- Primary Topic
- Pneumocystis jirovecii pneumonia detection and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Northwestern University
- National Institutes of Health